Beranda › Gangguan Defisit Perhatian dan Hiperaktivitas › New York
Uji klinis Gangguan Defisit Perhatian dan Hiperaktivitas di New York
7 studi untuk Gangguan Defisit Perhatian dan Hiperaktivitas mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- The Medical Research Network, LLC, New York
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07759154Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaFase 4
48 Months – 69 Months · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Staten Island
Menerima pesertaFase 3
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Staten Island
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07717892An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
- NYU Langone Health, New York
Menerima pesertaFase 4
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT06577779AWARE: Management of ADHD in Autism Spectrum Disorder
- University of Rochester, Rochester
Menerima pesertaFase 4
Usia 4 hingga 17 · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT05916339A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaSukarelawan sehat diterima
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 11 Des 2024 · NCT06728969Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.